Hims & Hers Health Inc [HIMS] stock is trading at $57.65, up 0.58%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The HIMS shares have gain 14.43% over the last week, with a monthly amount glided 39.22%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Hims & Hers Health Inc [NYSE: HIMS] stock has seen the most recent analyst activity on June 23, 2025, when Needham downgraded its rating to a Hold. Previously, Needham reaffirmed its Buy rating on June 04, 2025, and elevated its price target to $65. On April 29, 2025, downgrade downgraded it’s rating to Hold but maintained its price target of $30 on the stock. Morgan Stanley downgraded its rating to a Equal-Weight and increased its price target to $60 on February 18, 2025. Citigroup downgraded its rating to a Sell and raised its price target to $25 on January 10, 2025. BTIG Research started tracking with a Buy rating for this stock on January 07, 2025, and assigned it a price target of $35. In a note dated December 17, 2024, Morgan Stanley initiated an Overweight rating and provided a target price of $42 on this stock.
Hims & Hers Health Inc [HIMS] stock has fluctuated between $13.47 and $72.98 over the past year. Currently, Wall Street analysts expect the stock to reach $52 within the next 12 months. Hims & Hers Health Inc [NYSE: HIMS] shares were valued at $57.65 at the most recent close of the market. An investor can expect a potential drop of -9.8% based on the average HIMS price forecast.
Analyzing the HIMS fundamentals
Hims & Hers Health Inc [NYSE:HIMS] reported sales of 1.78B for the trailing twelve months, which represents a growth of 110.67%. Gross Profit Margin for this corporation currently stands at 0.77% with Operating Profit Margin at 0.06%, Pretax Profit Margin comes in at 0.07%, and Net Profit Margin reading is 0.09%. To continue investigating profitability, this company’s Return on Assets is posted at 0.18, Equity is 0.36 and Total Capital is 0.18. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.12.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 54.65 points at the first support level, and at 51.66 for the second support level. However, for the 1st resistance point, the stock is sitting at 60.29, and for the 2nd resistance point, it is at 62.94.
Ratios To Look Out For
For context, Hims & Hers Health Inc’s Current Ratio is 1.59. Further, the Quick Ratio stands at 1.32, while the Cash Ratio is 0.98. Considering the valuation of this stock, the price to sales ratio is 7.23, the price to book ratio is 23.47 and price to earnings (TTM) ratio is 83.92.
Transactions by insiders
Recent insider trading involved Chi Michael, Chief Commercial Officer, that happened on Jul 23 ’25 when 13750.0 shares were sold. Chief Commercial Officer, Chi Michael completed a deal on Jul 24 ’25 to sell 2100.0 shares. Meanwhile, Officer Chi Michael bought 2100.0 shares on Jul 24 ’25.
